Literature DB >> 18494740

Ischaemic change after intravitreal bevacizumab (Avastin) injection for macular oedema secondary to non-ischaemic central retinal vein occlusion.

Kwan Soo Kim, Hae Ran Chang, Sujeong Song.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18494740     DOI: 10.1111/j.1755-3768.2008.01175.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  15 in total

1.  Intravitreal bevacizumab for severe vaso-occlusive retinopathy in systemic lupus erythematosus.

Authors:  Won June Lee; Hee Yoon Cho; Yoon Jung Lee; Byung Ro Lee; Jae Pil Shin
Journal:  Rheumatol Int       Date:  2011-09-28       Impact factor: 2.631

2.  Progression of impending central retinal vein occlusion to the ischemic variant following intravitreal bevacizumab.

Authors:  Na Rae Kim; Hee Seung Chin
Journal:  Korean J Ophthalmol       Date:  2010-06-05

3.  Quantifying the increasing use of anti-vascular endothelial growth factor therapy in ophthalmology.

Authors:  Jonathan A Micieli; Andrew Micieli
Journal:  Mcgill J Med       Date:  2011-06

4.  Insight into 144 patients with ocular vascular events during VEGF antagonist injections.

Authors:  Ahmad M Mansour; Maha Shahin; Peter K Kofoed; Maurizio B Parodi; Michel Shami; Stephen G Schwartz
Journal:  Clin Ophthalmol       Date:  2012-03-06

5.  Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization.

Authors:  Abdallah A Ellabban; Akitaka Tsujikawa; Ken Ogino; Sotaro Ooto; Kenji Yamashiro; Akio Oishi; Nagahisa Yoshimura
Journal:  Clin Ophthalmol       Date:  2012-05-30

6.  An experimental study of VEGF induced changes in vasoactivity in pig retinal arterioles and the influence of an anti-VEGF agent.

Authors:  Er-Ning Su; Stephen J Cringle; Ian L McAllister; Dao-Yi Yu
Journal:  BMC Ophthalmol       Date:  2012-05-29       Impact factor: 2.209

7.  Ganglion Cell Complex Evaluation in Exudative Age-Related Macular Degeneration after Repeated Intravitreal Injections of Ranibizumab.

Authors:  Andrea Perdicchi; Giacomo Peluso; Daniela Iacovello; Marco Balestrieri; Martina Delle Fave; Solmaz Abdolrahimzadeh; Gian Luca Scuderi; Vito Fenicia; Santi Maria Recupero
Journal:  Biomed Res Int       Date:  2015-06-08       Impact factor: 3.411

8.  Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration.

Authors:  Tomoharu Nishimura; Shigeki Machida; Tomomi Harada; Daijiro Kurosaka
Journal:  Clin Ophthalmol       Date:  2012-07-13

9.  Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease.

Authors:  Nikolaus Feucht; Etienne Michael Schönbach; Ines Lanzl; Konstantin Kotliar; Chris Patrick Lohmann; Mathias Maier
Journal:  Clin Ophthalmol       Date:  2013-01-18

10.  Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients.

Authors:  Vincenzo Isola; Alfredo Pece; Claudio Massironi; Simone Reposi; Fabio Dimastrogiovanni
Journal:  Clin Ophthalmol       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.